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Erika van den Bogaart*, 1, Gerard J. Schoone 1, Emily R. Adams 2, Henk D.F.H. Schallig
Royal Tropical Institute (KIT), Department of Biomedical Research, Parasitology Unit, Meibergdreef 39, Amsterdam 1105 AZ, The NetherlandsThe authors regret that there was an error in a sentence in the section 2.5. The corrected sentence is as below:
For b-2M, the sense primer 50-GGCTATCCAGCGTACTCCAA-30 and the antisense primer 50-GATGAAACCCAGACACATAGCA-30 located
within exon 1 and 2 (Mahoney et al., 2004) were used, together with the ﬂuorescent probe 50-ACTCACGTCATCCAGCAGAG-30, labeled at the
50-terminus with the reporter dye Texas red and at the 30-terminus with the quenching dye.
The authors would like to apologise for any inconvenience caused.DOI of original article: http://dx.doi.org/10.1016/j.ijpddr.2013.11.001.
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